Activated Murine B Lymphocytes and Dendritic Cells Produce a Novel CC Chemokine which Acts Selectively on Activated T Cells

Genes were isolated using the suppression subtractive hybridization method by stimulation of pro/pre B cells with anti-CD40 and interleukin (IL)-4 to mature Sμ-Sε–switched cells. One of the strongly upregulated genes encodes a novel murine CC chemokine we have named ABCD-1. The ABCD-1 gene has three exons separated by 1.2- and 2.7-kb introns. It gives rise to a 2.2-kb transcript containing an open reading frame of 276 nucleotides. Two polyadenylation sites are used, giving rise to cDNAs with either 1550 or 1850 bp of 3′ untranslated regions. The open reading frame encodes a 24 amino acid–long leader peptide and a 68 amino acid–long mature protein with a predicted molecular mass of 7.8 kD. ABCD-1 mRNA is found in highest quantities in activated splenic B lymphocytes and dendritic cells. Little chemokine mRNA is present in lung, in unstimulated splenic cells, in thymocytes, and in lymph node cells. No ABCD-1 mRNA is detected in bone marrow, liver, kidney, or brain, in peritoneal exudate cells as well as in the majority of all unstimulated B lineage cells tested. It is also undetectable in Concanavalin A–activated/IL-2–restimulated splenic T cells, and in bone marrow–derived IL-2–induced natural killer cells and IL-3–activated macrophages. Recombinant ABCD-1 revealed a concentration-dependent and specific migration of activated splenic T lymphoblasts in chemotaxis assays. FACS® analyses of migrated cells showed no preferential difference in migration of CD4+ versus CD8+ T cell blasts. Murine as well as human T cells responded to ABCD-1. Freshly isolated cells from bone marrow, thymus, spleen, and lymph node, IL-2–activated NK cells, and LPS-stimulated splenic cells, all did not show any chemotactic response. Thus, ABCD-1 is the first chemokine produced in large amounts by activated B cells and acting selectively on activated T lymphocytes. Therefore, ABCD-1 is expected to play an important role in the collaboration of dendritic cells and B lymphocytes with T cells in immune responses.

[1]  T. Boone,et al.  Molecular Cloning and Functional Characterization of a Novel CC Chemokine, Stimulated T Cell Chemotactic Protein (STCP-1) That Specifically Acts on Activated T Lymphocytes* , 1997, The Journal of Biological Chemistry.

[2]  C. Berek,et al.  Maturation of the immune response in germinal centers , 1991, Cell.

[3]  A. Rolink,et al.  The SCID but Not the RAG-2 Gene Product Is Required for Sμ–Sε Heavy Chain Class Switching , 1996 .

[4]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[5]  D. Largaespada,et al.  Lymphotactin: a cytokine that represents a new class of chemokine. , 1994, Science.

[6]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[7]  M. Ogawa,et al.  B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac. , 1988, The EMBO journal.

[8]  B. Dobberstein,et al.  Primary structure of the gene for the murine Ia antigen‐associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine‐rich domain highly homologous to a repetitive sequence of thyroglobulin. , 1987, The EMBO journal.

[9]  D. Fearon,et al.  A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors , 1996, The Journal of experimental medicine.

[10]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[11]  A. Rolink,et al.  Induction of sterile transcription from the kappa L chain gene locus in V(D)J recombinase-deficient progenitor B cells. , 1995, International immunology.

[12]  G. Nicolson,et al.  Derivation of lymphoma variants with reduced sensitivity to plant lectins. , 1974, Journal of the National Cancer Institute.

[13]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[14]  C. Snapper,et al.  Towards a comprehensive view of immunoglobulin class switching. , 1993, Immunology today.

[15]  G. Thorbecke,et al.  Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. , 1983, Journal of immunology.

[16]  C. Ruedl,et al.  Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering , 1997, European journal of immunology.

[17]  K. Toellner,et al.  The changing preference of T and B cells for partners as T‐dependent antibody responses develop , 1997, Immunological reviews.

[18]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[19]  P. Ralph,et al.  Murine B cell leukemia line with inducible surface immunoglobulin expression. , 1978, Journal of immunology.

[20]  D H Sachs,et al.  Establishment and characterization of BALB/c lymphoma lines with B cell properties. , 1979, Journal of immunology.

[21]  Alan I. Alpert,et al.  The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.

[22]  P. Gray,et al.  Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.

[23]  P. Allavena,et al.  Human Macrophage–derived Chemokine (mdc), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells , 1997 .

[24]  M. Brown,et al.  Inhibition of HIV-1 infection by the beta-chemokine MDC. , 1997, Science.

[25]  C. Benoist,et al.  The immune system of mice lacking conventional MHC class II molecules. , 1994, Advances in immunology.

[26]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[27]  Jun Zhang,et al.  Sites of specific B cell activation in primary and secondary responses to T cell‐dependent and T cell‐independent antigens , 1991, European journal of immunology.

[28]  M. Cohn,et al.  Variability in the Lambda Light Chain Sequences of Mouse Antibody , 1970, Nature.

[29]  D. Conrad,et al.  Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII). , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Mcclanahan,et al.  Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. , 1997, Journal of immunology.

[31]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[32]  M. Leptin,et al.  Monoclonal antibodies specific for murine IgM I. Characterization of antigenic determinants on the four constant domains of the μ heavy chain , 1984, European journal of immunology.

[33]  F. Alt,et al.  Ordered rearrangement of immunoglobulin heavy chain variable region segments. , 1984, The EMBO journal.

[34]  A. Rolink,et al.  Long‐term proliferating early pre B cell lines and clones with the potential to develop to surface Ig‐positive, mitogen reactive B cells in vitro and in vivo. , 1991, The EMBO journal.

[35]  A. Krensky,et al.  Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. , 1992, Kidney international.

[36]  T. Schall,et al.  Chemokines, leukocyte trafficking, and inflammation. , 1994, Current opinion in immunology.

[37]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[38]  C. Arpin,et al.  Germinal center development , 1997, Immunological reviews.

[39]  R. Steinman,et al.  Dendritic cells in the T‐cell areas of lymphoid organs , 1997, Immunological reviews.

[40]  G. Klaus,et al.  The Follicular Dendritic Cell: Its Role in Antigen Presentation in the Generation of Immunological Memory , 1980, Immunological reviews.

[41]  E. Neilson,et al.  Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. , 1994, Journal of immunology.

[42]  A. Garzino-Demo,et al.  Inhibition of HIV-1 Infection by the β-Chemokine MDC , 1997 .

[43]  G. Thorbecke,et al.  Relationship of germinal centers in lymphoid tissue to immunologic memory. V. The effect of prednisolone administered after the peak of the primary response. , 1971, Journal of immunology.

[44]  R. Callard,et al.  Non-antigen signals for B-cell growth and differentiation to antibody secretion. , 1993, Current opinion in immunology.

[45]  A. Zlotnik,et al.  Chemokines and lymphocyte biology. , 1996, Current opinion in immunology.

[46]  J. D. Thomas,et al.  Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. , 1994, Journal of immunology.

[47]  K. Rajewsky,et al.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. , 1979, Journal of immunology.

[48]  Andreas Radbruch,et al.  Immunoglobulin class switching: molecular and cellular analysis. , 1990, Annual review of immunology.

[49]  P. Le Bouteiller.  HLA class I chromosomal region, genes, and products: facts and questions. , 1994, Critical reviews in immunology.

[50]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[51]  R. Coffman,et al.  A unique series of lymphomas related to the Ly-1+ lineage of B lymphocyte differentiation. , 1984, Journal of immunology.

[52]  D. Walper,et al.  Modulation of Macrophage Inflammatory Protein-1α and Its Receptors in Human B-Cell Lines Derived from Patients with Acquired Immunodeficiency Syndrome and Burkitt's Lymphoma , 1997 .

[53]  L. Goldstein,et al.  Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells. , 1988, Nucleic acids research.

[54]  N. Warner,et al.  Flow Cytometry Analysis of Murine B Cell Lymphoma Differentiation , 1979, Immunological reviews.

[55]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[58]  David Baltimore,et al.  Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: Rearrangement of heavy but not light chain genes , 1981, Cell.

[59]  N. Yoshida,et al.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.

[60]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[61]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[62]  G. Köhler,et al.  A better cell line for making hybridomas secreting specific antibodies , 1978, Nature.

[63]  A. Lanzavecchia,et al.  The use of hybrid hybridomas to target human cytotoxic T lymphocytes , 1987, European journal of immunology.

[64]  I. Schneider,et al.  Cell lines derived from late embryonic stages of Drosophila melanogaster. , 1972, Journal of embryology and experimental morphology.

[65]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[66]  T. Schall,et al.  Molecular cloning and expression of the murine RANTES cytokine: structural and functional conservation between mouse and man , 1992, European journal of immunology.

[67]  M. Baggiolini,et al.  CC chemokines in allergic inflammation. , 1994, Immunology today.

[68]  D. Gray,et al.  B-cell memory is short-lived in the absence of antigen. , 1991, Nature.

[69]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[70]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[71]  A. Rolink,et al.  The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. , 1996, Immunity.

[72]  F. Melchers,et al.  Induction of immunoglobulin M synthesis and secretion in bone-marrow-derived lymphocytes by locally concentrated concanavalin A. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[73]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[74]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[75]  P. Ralph.  Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin. , 1973, Journal of immunology.